STOCK TITAN

HeartBeam, Inc. (BEAT) awards 167,760 RSUs to CFO as 2025 bonus

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cruickshank Tim reported acquisition or exercise transactions in this Form 4 filing.

HeartBeam, Inc. reported that CFO Tim Cruickshank received a grant of 167,760 shares of common stock in the form of Restricted Stock Units on July 24, 2026 under the 2022 Equity Incentive Plan. The RSUs vested in full on the grant date as shares-in-lieu-of-cash for the 2025 Bonus Program, increasing his directly held shares to 239,990.

Positive

  • None.

Negative

  • None.
Insider Cruickshank Tim
Role CFO
Type Security Shares Price Value
Grant/Award Common Stock F1 167,760 $0.00 $0.00
Holdings After Transaction: Common Stock — 239,990 shares (Direct)
Footnotes (1)
  1. F1. Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.
RSU shares granted 167,760 shares Restricted Stock Units granted to CFO on July 24, 2026
Share price per RSU share $0.0000 per share Reported transaction price for RSU grant settlement in shares
Shares held after transaction 239,990 shares Total common shares directly held by CFO following the grant
Grant date July 24, 2026 Date RSUs were granted and fully vested
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") granted on July 24, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2022 Equity Incentive Plan financial
"granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan"
shares-in-lieu-of-cash financial
"settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash"
2025 Bonus Program financial
"relate to the settlement of the 2025 Bonus Program, whereby Executives received"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did HeartBeam (BEAT) report for CFO Tim Cruickshank?

HeartBeam reported that CFO Tim Cruickshank received 167,760 shares of common stock via Restricted Stock Units on July 24, 2026. The grant fully vested that day and was issued as shares-in-lieu-of-cash for his 2025 Bonus Program.

How many HeartBeam (BEAT) shares did the CFO receive in the latest equity grant?

CFO Tim Cruickshank received a grant of 167,760 shares of HeartBeam common stock. These shares came from Restricted Stock Units that vested immediately and were granted under the HeartBeam, Inc. 2022 Equity Incentive Plan as part of his 2025 bonus settlement.

What plan governed the RSU grant to HeartBeam (BEAT) CFO Tim Cruickshank?

The RSU grant to CFO Tim Cruickshank was made under the HeartBeam, Inc. 2022 Equity Incentive Plan. The award vested in full on the July 24, 2026 grant date and was used to settle the 2025 Bonus Program in stock instead of cash.

How many HeartBeam (BEAT) shares does the CFO hold after this Form 4 transaction?

After the grant, CFO Tim Cruickshank directly holds 239,990 shares of HeartBeam common stock. This reflects the addition of 167,760 vested RSU shares that were issued in lieu of cash for his 2025 bonus.

Was the HeartBeam (BEAT) CFO equity grant a cashless bonus settlement?

Yes. The filing states the RSUs relate to the settlement of the 2025 Bonus Program, where executives received shares-in-lieu-of-cash. CFO Tim Cruickshank’s 167,760 RSUs vested immediately and were paid entirely in stock rather than cash.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cruickshank Tim

(Last)(First)(Middle)
2118 WALSH AVE
SUITE 210

(Street)
SANTA CLARA CALIFORNIA 95050

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/24/2026A167,760(1)A$0239,990D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.
/s/ Tim Cruickshank07/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)